Matthew E. Korenberg - Dec 5, 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
PRESIDENT & CHIEF OPERATING
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Octavio Espinoza
Stock symbol
LGND
Transactions as of
Dec 5, 2023
Transactions value $
-$118,266
Form type
4
Date filed
12/6/2023, 03:27 PM
Previous filing
Jul 10, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$118K -1.98K -2% $59.61 97.1K Dec 5, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.